An FDA drug approval can get a biotech stock to skyrocket up to 1000%. We help you find out about approvals before everyone else.
The entire market is swinging because of events caused by COVID-19. Find out about supply chain disruptions, commodity movements and vaccine developments to stay one step ahead of everyone else.
Decide whether you want to trade broader markets or biopharmaceuticals in particular (or both).
Get a summary of everything you need to know, including company name, ticker, market cap, last traded price, and a summary of the event in question.
Make strategic moves before the market can and profit.
STATISTICS ABOUT US
Tiger-Johnson is currently in the process of developing integration so that you can automatically invest in high yielding approvals without worrying about missing out.
In 2019, Shakeel Hussein realized that there were huge inefficiencies in the presentation of financial information. Most news was delivered hours after the fact, meaning that retail investors always found out news after the stock rose.
With this in mind, he founded Tiger-Johnson Holdings with the goal of delivering information before a stock price jump rather than after.
Tiger Johnson Holdings has since expanded to include a portfolio, real estate fund, and a number of other ventures.
Safeer Abbas plays an instrumental role at Tiger Johnson, and is responsible for leading the development team towards developing and perfecting algorithms.
His systems use millions of data points to detect approvals and compile a report.
Teaming up with Shakeel and Safeer, Sajjad is the financial head of Tiger Johnson Holdings. Since the beginning of 2020, he has managed the Tiger Johnson portfolio, real estate fund, and has been directly involved in the development of a system that uses deep intelligence to spot gaps in the markets and capitalize on them.
